A Temple researcher has been awarded a grant from the University City Science Center to develop a tumor-inhibiting protein to treat acute myeloid leukemia (AML). George P. Tuszynski, a professor of neuroscience in Temple’s School of Medicine and professor of biology in the College of Science and Technology, discovered the novel protein Angiocidin and will receive the $200,000 proof-of-concept grant as part of UCSC’s QED Program.